Pathology and Epidemiology of Cancer.
Pathology and Epidemiology of Cancer. - Department of Pathology Dana-Farber Cancer Institute and Brigham & Women’s Hospital, Harvard Medical School Boston, MA USA | Springer International Publishing Switzerland | 2017 - 664 Pages Includes References and Index
Pathology and Epidemiology of Cancer integrates the disciplines of Cancer Pathology and Epidemiology to provide a synergistic and complementary approach to understanding the molecular mechanisms of cancer. This book provides relevant information on the diagnostic, prognostic and predictive molecular pathology of cancer. Epidemiological studies, including descriptive epidemiology, risk factors and molecular mechanisms of disease, inform on the etiology and progression of cancer. The text concentrates on major cancers that are currently prevalent and those for which substantial molecular, pathological and epidemiological data is available. Each section is designed to provide an overview of that cancer type in terms of basic biology, review the current epidemiological data surrounding that cancer type and provide information on common practices and challenges related to the molecular pathology of that cancer type. Several relevant techniques in molecular pathology, which facilitate diagnosis and treatment are also explored.
Pathology and Epidemiology of Cancer provides a succinct and comprehensive overview of multiple cancer types to guide clinicians during patient care and to guide scientists for innovations in research. It represents an integral resource for pathologists, epidemiologists, medical students as well as translational, basic and clinical science researchers who are all working to progress the field of cancer in terms of diagnosis, treatment and prevention.
978-3-319-35151-3 978-3-319-35153-7 (eBook) = adenocarcinoma adenoma associated benign Biomarkers bladder cancer breast cancer breast cancer risk Cancer Epidemiol Biomarkers Cancer Res case-control study chemotherapy chromosome Clin Oncol clinical cohort studies colon colorectal cancer common CRC cytoplasm diagnosis differentiation disease DNA ductal EGFR endometrial cancer Epidemiol Biomarkers Prev Epidemiology epithelial Epub estrogen exposure Fig G gene expression genetic genomic germline glands grade HCC HER2 histologic hormone identified increased risk Int J Cancer intake invasive kinase lesions lung cancer lymph node lymphoma malignant markers melanocytic melanoma meningioma meta-analysis metastatic molecular mortality mucinous mutations myeloma Natl Cancer Inst neoplasms noma ovarian cancer pancreatic cancer papillary pathology pathway patients pattern PCa phenotype pooled analysis prognostic proliferation prostate cancer protein PubMed PMID RCC receptor renal cell carcinoma risk factors screening sequencing smoking stage staining stem cells stroma subtypes Surg Pathol survival syndrome target therapy tion tissue treatment tumor cells urothelial carcinoma variants vitamin vitamin D women
2016940001
--Biology—Research, Medical / Clinical Medicine, Medical / Pathology, Medical / Research, Medicine—Research, Pathology, Science / Life Sciences / Molecular Biology, Medical / Oncology / General, Cancer -- Epidemiology, Carcinogenesis, Medicine, Medicine and Public Health, Molecular Medicine, Molecular biology.